AVF-JOBST Clinical Research Grant
The AVF 2024 AVF-JOBST Clinical Research Grant will provide a $85,000 grant over two years for original, clinical research in venous diseases, lymphatic diseases, or lipedema with an emphasis on:
- Prevention of disease and its progression
- Diagnosis of disease
- The science of management of the above conditions, especially with compression therapy
- Residents and fellows in a training program located in the United States
- Physicians who have completed their training within the past ten (10) years and are currently based in the United States
- Applicants who have not previously received this award
AVF-JOBST Clinical Research Grant Funding
Eligibility for the AVF-JOBST Clinical Research Grant
- The AVF-JOBST Clinical Research Grant will be awarded to an original, clinical research project in venous diseases, lymphatic diseases, or lipedema with an emphasis on: prevention of disease and its progression, diagnosis of disease, or the science of management of the above conditions, especially with compression therapy.
- Applicants must be a resident or fellow in a training program located in the United States or a physician who has completed their training within the past ten (10) years, have not previously received this award and are currently based in the United States.
- Either the applicant or their mentor must be an AVF Member at the time of submission. The awardee is expected to join the AVF and maintain their membership for the duration of the grant period.
- The applicant’s mentor and institution must also be located in the United States.
- A no-cost extension will be permitted to allow for variability in research progression on a case-by-case basis only, upon written request by the applicant, and will require approval from the Research Committee, Research Council Chair, and Board of Directors.
- All residents and fellows are required to include a letter from the Program Director confirming a two-year commitment to the project and enough time dedicated to research during this period.
- The applicant must attest, in their cover letter, that they are not currently excluded by the Office of the Inspector General from participation in Medicare, Medicaid, or other Federal health care programs.
- The awardee’s institution must provide a signed W-9 prior to the initial disbursement. Subsequent requests for disbursement must be accompanied by a formal letter of request for funding, an itemized invoice correlating to the originally submitted budget, and an update on the status of the research project. The Research Committee will review these requests prior to approving the disbursement.
- The awardee is required to attend the AVF Annual Meeting to receive the award as well as the subsequent two Annual Meeting to provide a YEAR 1 preliminary report on the grant project and YEAR 2 final report on the grant project. This requirement is mandatory.
Application Process for the AVF-JOBST Clinical Research Grant
- A completed Application (PDF)
- A completed Application (Word)
- The applicant’s curriculum vitae
- The mentor’s curriculum vitae
- A letter of support from the sponsor (mentor) of the project including verification of resources available to support the project
- If neither the applicant nor their mentor is an AVF member, the applicant must submit an application for membership prior to submitting their grant application
- Submission deadline: Extended to Friday, September 15, 2023
AVF-JOBST Grant History
In 1950, Conrad Jobst founded JOBST in Toledo, Ohio. In 1957, after Conrad’s death, his wife Caroline Jobst successfully grew the business. In the 1980’s, Caroline played an influential role in the early years of the American Venous Forum. In 1995, in association with the American Venous Forum, JOBST initiated the AVF-JOBST Grant in Venous and Lymphatic Diseases to further Conrad’s and Caroline’s legacy of innovation.
AVF-JOBST Clinical Research Grant Funding
In 1995, the AVF, in collaboration with JOBST, initiated the JOBST Research Grant in Venous and Lymphatic Diseases. For more than 26 years, the research developed by grant recipients has helped advance the understanding and treatment of venous and lymphatic diseases.